SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML | Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
Other
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. |
Displaying 51 - 60 of 238 results
Data provided by Kaleidoscope.